IBX 13.0% 4.0¢ imagion biosystems limited

Steady decline, page-3

  1. 1,134 Posts.
    lightbulb Created with Sketch. 115
    go through some earlier posts and you’ll get the full story of lack of enrolment in clinical trials, and (misplaced) lack of confidence in the CEO. Against that you’ll see the increasing range of collaborations. If you’re confident in the foundations then I wouldn’t worry.

    easy to do the research.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.